4Cristina R. Ferrone,Murray F. Brennan,Mithat Gonen,Daniel G. Coit,Yuman Fong,Sun Chung,Laura Tang,David Klimstra,Peter J. Allen. Pancreatic Adenocarcinoma: The Actual 5-Year Survivors[J] 2008,Journal of Gastrointestinal Surgery(4):701~706
3Knoll MR, Rudnitzki D, Sturm J, Manegold BC, Post S, Jaeger TM. Correlation of postoperative survival and angiogenic growth factors in pancreatic carcinoma. Hepatogastroenterology 2001; 48:1162-1165
4Nagakawa Y, Aoki T, Kasuya K, Tsuchida A, Koyanagi Y. Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metaUoproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer, Pancreas 2002; 24:169-178
5Bachler P, Reber HA, Buchler M, Shrinkante S,Buchler MW, Friess H, Semenza GL, Hines OJ. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer. Pancreas 2003; 26:56-64
6Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000; 407:242-248
7Ikeda N, Adachi M, Taki T, Huang C, Hashida H, Takabayashi A, Sho M, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M. Prognostic significance of angiogenesis in human pancreatic cancer. BrJ Cancer 1999; 79:1553-1563
8Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 1992; 3:65-71
9Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, Bevilacqua G, Campani D.Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004; 57: 630-636
10Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2000; 2:737-744